首页> 外文期刊>Journal of vascular surgery >Gore Iliac Branch Endoprosthesis for treatment of bilateral common iliac artery aneurysms
【24h】

Gore Iliac Branch Endoprosthesis for treatment of bilateral common iliac artery aneurysms

机译:Gore Iliac分支内置假体用于治疗双侧髂动脉肌动脉瘤

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

ObjectiveThe Gore Iliac Branch Endoprosthesis (IBE; W. L. Gore & Associates, Flagstaff, Ariz) has recently been approved by the Food and Drug Administration for treatment of common iliac artery (CIA) aneurysms. Despite early excellent results in clinical trial, none of 63 patients were treated for bilateral iliac aneurysms. The goal of this study was to examine real-world experience using the Gore IBE for bilateral CIA aneurysms. MethodsA retrospective review of an international multicenter (16 U.S., 8 European) experience using the Gore IBE to treat bilateral CIA aneurysms was performed. Cases were limited to those occurring after Food and Drug Administration approval (February 2016) in the United States and after CE mark approval (November 2013) in Europe. Demographics of the patients, presentation, anatomic characteristics, and procedural details were captured. ResultsThere were 47 patients (45 men; mean age, 68?years; range, 41-84?years) treated with bilateral Gore IBEs (27 U.S., 20 European). Six patients (12.7%) were symptomatic and 12 (25.5%) patients were treated primarily for CIA aneurysm (aorta?<5.0?cm). Mean CIA diameter was 40.3?mm. Four patients had aneurysmal internal iliac arteries (IIAs). Two of these were sealed proximally at the IIA aneurysm neck and two required coil embolization of IIA branches to achieve seal in the largest first-order branches. Technical success was achieved in 46 patients (97.9%). No type I or type III endoleaks were noted. There was no significant perioperative morbidity or mortality. IIA branch adjunctive stenting was required in four patients (one IIA distal dissection, three kinks). On follow-up imaging available for 40 patients (85.1%; mean, 6.5?months; range, 1-36?months), 12 type II endoleaks (30%) and no type I or type III endoleaks were detected. Two of 80 (2.5%) IIA branches imaged were occluded; one was intentionally sacrificed perioperatively. ConclusionsPreservation of bilateral IIAs in repair of bilateral CIA aneurysms can be performed safely with excellent technical success and short-term patency rates using the Gore IBE device. Limb and branch occlusions are rare, usually are due to kinking, and can almost always be treated successfully with stenting.
机译:目的血糖肝分支内止血剂(IBE; W.L.Gore&Associates,Flagstaff,Ariz)最近被食品和药物管理局批准用于治疗常见的髂动脉(CIA)动脉瘤。尽管临床试验早期出现优异的结果,但为双侧髂动脉瘤治疗了63名患者。本研究的目标是研究使用Gore Ibe for BialaTial Cia动脉瘤的真实体验。 MethaSA使用Gore Ibe治疗双侧CIA动脉瘤的国际多中心(1600.,8欧洲)经验的回顾性审查。案件仅限于美国在美国食品和药物管理局批准(2016年2月)和CE Mark批准(2013年11月)在欧洲之后发生的案件。捕获了患者的人口统计,呈现,解剖特征和程序细节。结果是47名患者(45名男子;平均年龄,68岁;范围,41-84岁,41-84岁)治疗双侧血腥IBES(27美国,20欧洲)。六名患者(12.7%)是症状的,12名(25.5%)患者主要用于CIA动脉瘤(主动脉θ<5.0μm)治疗。平均CIA直径为40.3ΩΩmm。四名患者有动脉瘤内部髂动脉(IIA)。其中两种在IIA动脉瘤颈部近端密封,两个所需的IIA分支栓塞在最大的一阶分支中实现密封。在46名患者中取得了技术成功(97.9%)。没有注意到I类型或III型endoReaks。没有显着的围手术期发病率或死亡率。在四名患者中需要IIA分支辅助支架(一个IIA远端解剖,三个扭结)。关于40名患者的后续成像(85.1%;平均值,6.5?几个月;范围,1-36?月),12型II型Endoleaks(30%),没有I型或III型胚胎胚胎。 80个(2.5%)IIa分支的含量堵塞;一个故意围手术自牺牲。结论双侧IIA在双侧CIA动脉瘤修复中的预期可以安全地进行良好的技术成功和使用GORE IBE设备的短期通畅率。肢体和分支闭塞是罕见的,通常是由于扭结,并且几乎总是通过支架成功治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号